Market revenue in 2023 | USD 6.5 million |
Market revenue in 2030 | USD 13.2 million |
Growth rate | 10.7% (CAGR from 2023 to 2030) |
Largest segment | Radiofrequency ablation |
Fastest growing segment | Radiofrequency Ablation |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Radiofrequency Ablation, Microwave Ablation |
Key market players worldwide | Boston Scientific Corp, BVM Medical, Integra Lifesciences Holdings Corp, Johnson & Johnson, Medtronic PLC, Olympus Corp, Terumo Corp, Theraclion, Medwave, StarMed |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to thyroid ablation devices market will help companies and investors design strategic landscapes.
Radiofrequency ablation was the largest segment with a revenue share of 49.23% in 2023. Horizon Databook has segmented the Japan thyroid ablation devices market based on radiofrequency ablation, microwave ablation covering the revenue growth of each sub-segment from 2018 to 2030.
More than 25.0% of Japan’s population is aged over 65 years, and with increasing healthcare GDP, its thyroid ablation devices market is expected to flourish over the forecast period. With high healthcare expenditure, Japan’s healthcare system is witnessing a transition in service portfolio from preventive care to nursing care in disease management.
The prevalence of thyroid cancer has been constantly increasing in both, females and males, in Japan, with a greater prevalence in females than males. Furthermore, The Cancer Control Act strongly promotes and development of cancer medical facilities and services, early cancer detection, radiotherapy & chemotherapy, early-stage adoption of palliative care, and cancer research.
Such initiatives are anticipated to facilitate market growth. In Japan, the Pharmaceuticals and Medical Devices Agency (PMDA), along with the Ministry of Health, Labour and Welfare, regulates medical devices based on the risk associated with the device.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan thyroid ablation devices market , including forecasts for subscribers. This country databook contains high-level insights into Japan thyroid ablation devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account